Lactate-rich tumor employs the KAT5–HIF1α axis to modulate the activity of the hypoxia pathway and facilitates tumor progression

Substantial evidence shows that hypoxia-inducible factor 1α (HIF1α) up-regulates glycolytic enzymes and promotes lactate production, which contributes to “Warburg Effect.” Nevertheless, the impact of lactate or lactylation modification on hypoxia signaling pathways within the tumor microenvironment remains largely unclear. Here, we report that lactate can induce the upregulation of hypoxia pathway activity in a HIF1α-dependent manner. We identified that KAT5 as a lysine lactyltransferase of HIF1α and the “writer” responsible for lactylation at HIF1α K389, K460, K674, and K682, and HDAC2 as a HIF1α de-lactylase. The lactylation-deficient mutant of HIF1α (HIF1α 4KR ) reduced HIF1α stability, along with down-regulating hypoxia-mediated angiogenesis, metastasis, apoptosis, and glycolysis. Mechanistically, the HIF1α 4KR mutant enhances the binding of HIF1α to von Hippel-Lindau tumor suppressor protein (VHL), facilitating its degradation. MG149, a KAT5 inhibitor, can enhance the efficacy of anti-programmed cell death protein 1 (PD-1)-based combination immunotherapy in a murine model by suppressing hypoxia pathway activity in tumor cells and potentiating the cytotoxic function of CD8 + T cells. Clinically, lactylated HIF1α and KAT5 are up-regulated in breast cancer tissues compared with adjacent tissues. Notably, elevated levels of HIF1α lactylation and KAT5 expression were observed in resistant cancer specimens from triple-negative breast cancer patients who had undergone neoadjuvant chemoimmunotherapy. Our results indicate that the tumor lactate microenvironment promotes the formation of the tumor hypoxic microenvironment by hijacking and lactylating HIF1α, and the KAT5–HIF1α Kla axis presents a promising therapeutic target for hypoxic tumors.

Authors

Institutions

Publication Details

Journal
Proceedings of the National Academy of Sciences
Published
2026-11-19
DOI
https://doi.org/10.1073/pnas.2627324123
Primary Topic
Cancer, Hypoxia, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Lactate-rich tumor employs the KAT5–HIF1α axis to modulate the activity of the hypoxia pathway and facilitates tumor progression

Zhengyan Liang, Yongkang Zou, Zhaoxiang Wang, Zhiguo Wang et al.
Proceedings of the National Academy of Sciences
Cancer, Hypoxia, and Metabolism
article

Lactate-rich tumor employs the KAT5–HIF1α axis to modulate the activity of the hypoxia pathway and facilitates tumor progression

Zhengyan Liang, Yongkang Zou, Zhaoxiang Wang, Zhiguo Wang, Xia Kong, Ying Xue, Yuan Jiao, Junzhi Zhou, Yingzhi Chen, Zhiwei He, Weixian Zhou, Jiayue Wen, Panpan Zhu, Hewen Ye
article en

Abstract

Substantial evidence shows that hypoxia-inducible factor 1α (HIF1α) up-regulates glycolytic enzymes and promotes lactate production, which contributes to “Warburg Effect.” Nevertheless, the impact of lactate or lactylation modification on hypoxia signaling pathways within the tumor microenvironment remains largely unclear. Here, we report that lactate can induce the upregulation of hypoxia pathway activity in a HIF1α-dependent manner. We identified that KAT5 as a lysine lactyltransferase of HIF1α and the “writer” responsible for lactylation at HIF1α K389, K460, K674, and K682, and HDAC2 as a HIF1α de-lactylase. The lactylation-deficient mutant of HIF1α (HIF1α 4KR ) reduced HIF1α stability, along with down-regulating hypoxia-mediated angiogenesis, metastasis, apoptosis, and glycolysis. Mechanistically, the HIF1α 4KR mutant enhances the binding of HIF1α to von Hippel-Lindau tumor suppressor protein (VHL), facilitating its degradation. MG149, a KAT5 inhibitor, can enhance the efficacy of anti-programmed cell death protein 1 (PD-1)-based combination immunotherapy in a murine model by suppressing hypoxia pathway activity in tumor cells and potentiating the cytotoxic function of CD8 + T cells. Clinically, lactylated HIF1α and KAT5 are up-regulated in breast cancer tissues compared with adjacent tissues. Notably, elevated levels of HIF1α lactylation and KAT5 expression were observed in resistant cancer specimens from triple-negative breast cancer patients who had undergone neoadjuvant chemoimmunotherapy. Our results indicate that the tumor lactate microenvironment promotes the formation of the tumor hypoxic microenvironment by hijacking and lactylating HIF1α, and the KAT5–HIF1α Kla axis presents a promising therapeutic target for hypoxic tumors.

Proceedings of the National Academy of SciencesVol. 123(47)
Hangzhou Normal University (CN), Guangdong Medical College (CN), Shenzhen Bay Laboratory (CN), Zhongshan People's Hospital (CN), Guangdong-Hongkong-Macau Joint Laboratory of Collaborative Innovation for Environmental Quality (CN), Guangzhou Medical University (CN)
Cancer, Hypoxia, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon